Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

263.81
Delayed Data
As of Jul 31
 +2.01 / +0.77%
Today’s Change
128.50
Today|||52-Week Range
349.08
+69.11%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close261.80
Today’s open261.51
Day’s range260.00 - 267.92
Volume208,566
Average volume (3 months)428,698
Market cap$6.4B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+34.86%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book24.47

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...+0.49+0.33%
IDXXIDEXX Laboratories I...+1.39+1.95%
SGENSeattle Genetics Inc+0.53+1.12%
TAROTaro Pharmaceutical ...+0.75+0.54%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$2.00
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts